about
Exploiting the Pleiotropic Antioxidant Effects of Established Drugs in Cardiovascular DiseaseA role for Th17 cells in the regulation of tertiary lymphoid folliclesInterleukin-17F gene polymorphism in patients with chronic immune thrombocytopenia.Increased interleukin-23 receptor(+) T cells in peripheral blood mononuclear cells of patients with systemic lupus erythematosus.Netting neutrophils induce endothelial damage, infiltrate tissues, and expose immunostimulatory molecules in systemic lupus erythematosus.Paradoxical effects of all-trans-retinoic acid on lupus-like disease in the MRL/lpr mouse model.High Affinity Antibodies against Influenza Characterize the Plasmablast Response in SLE Patients After Vaccination.IL-17 in obesity and adipogenesis.cAMP-responsive element modulator α (CREMα) suppresses IL-17F protein expression in T lymphocytes from patients with systemic lupus erythematosus (SLE).Hypersplenism in liver disease and SLE revisited: current evidence supports an active rather than passive process.Analysis of CD95 and CCR7 expression on circulating CD4(+) lymphocytes revealed disparate immunoregulatory potentials in systemic lupus erythematosusInterleukin-17 causes Rho-kinase-mediated endothelial dysfunction and hypertension.Biomarkers in systemic lupus erythematosus: challenges and prospects for the future.Clinical consequences of targeting IL-17 and TH17 in autoimmune and allergic disordersIncreased Set1 binding at the promoter induces aberrant epigenetic alterations and up-regulates cyclic adenosine 5'-monophosphate response element modulator alpha in systemic lupus erythematosus.cAMP responsive element modulator: a critical regulator of cytokine productionIL-17/IL-17 receptor system in autoimmune disease: mechanisms and therapeutic potential.Contributions of B cells to lupus pathogenesisLow-Dose IL-2 in the Treatment of Lupus.Regulation of Interleukin-17 Production.Distribution of human leukocyte antigen alleles in systemic lupus erythematosus patients with angiotensin converting enzyme insertion/deletion polymorphism.Administration of fasudil, a ROCK inhibitor, attenuates disease in lupus-prone NZB/W F1 female mice.Therapeutic potential of DCB-SLE1, an extract of a mixture of Chinese medicinal herbs, for severe lupus nephritis.Human embryonic mesenchymal stem cells alleviate pathologic changes of MRL/Lpr mice by regulating Th7 cell differentiation.APRIL levels strongly correlate with IL-17 in systemic lupus erythematosus.Targeting Regulatory T Cells to Treat Patients With Systemic Lupus Erythematosus.T Cell Receptor-Independent, CD31/IL-17A-Driven Inflammatory Axis Shapes Synovitis in Juvenile Idiopathic Arthritis
P2860
Q26801173-F72A96FE-5A26-47EE-854F-DA2239273110Q26851559-FC64ED99-C2F1-4170-81AF-22881CC3D669Q33395519-E198BFF3-B8D1-4A97-9B1E-F55CB91E5F7FQ34614005-E841388E-92E7-4DE1-A190-2EB9C606248EQ35059002-76D3361F-3725-493B-A3CD-679AF1260634Q35182476-F7D4AB6C-A54E-481C-9178-BDA2AFC33166Q35624357-FD3B2211-A573-4C0A-9EB4-33E3872E9842Q35676503-ADF8F9F1-DAAB-405F-A07E-91D95D83F09EQ35763036-8BCB2EC5-885C-48B7-ABF9-9578DF4F2E69Q35920464-B46E503C-D9AD-410B-86E2-1DC2EBA37442Q36441956-515BF82D-DA32-4AFC-A3B8-98F4BD27A759Q36641593-F948355B-DD64-406F-B11C-861FD60B5AE8Q37058781-EB778ABB-5763-449A-9AAA-E3FB5AFD587AQ37265849-E9714209-5634-487F-9965-911EA08037E4Q37436786-3FC699A8-B369-43A5-954B-A4A47E752525Q37477836-BB9123B5-1749-4565-B50F-B553E726807DQ37983096-BD9FB539-A1CE-4747-8046-02DB8CCF5F7AQ38170793-1AB2635B-6515-4697-B9FD-CB2CE6C4245FQ38979253-693C62D3-62BD-4859-A901-8F5E2515A602Q40508654-8C760487-55D7-4AA9-B0A3-8226AFC672D0Q41773447-A9ACF490-D7A4-41BE-8B14-FCB249D7236BQ43716866-2DCE06DF-05C7-45C4-B9FE-6B7D68535B2EQ50041410-903A4B0D-AB4C-4CE0-9AA7-480006329055Q50479906-E0A6B771-FE4F-4D90-B5E6-8CBA9732B7C4Q51125351-41F03D6E-63C8-4946-ACA4-03A27CE831C6Q55096330-A9B20B63-0655-47A7-A095-BA687E2AF75FQ58799147-09BB8ED8-6C96-45C2-9201-521719A5C441
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 06 April 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
IL-17 in systemic lupus erythematosus
@en
IL-17 in systemic lupus erythematosus.
@nl
type
label
IL-17 in systemic lupus erythematosus
@en
IL-17 in systemic lupus erythematosus.
@nl
prefLabel
IL-17 in systemic lupus erythematosus
@en
IL-17 in systemic lupus erythematosus.
@nl
P2860
P356
P1476
IL-17 in systemic lupus erythematosus
@en
P2093
George C Tsokos
José C Crispín
P2860
P304
P356
10.1155/2010/943254
P577
2010-04-06T00:00:00Z